Cargando…
Pharmacodynamic mechanisms behind a refractory state in inflammatory bowel disease
BACKGROUND AND AIMS: Biological therapy for inflammatory bowel disease is efficient in many cases but not all. The underlying molecular mechanisms behind non-response to biological therapy in inflammatory bowel disease are poorly described. Therefore, we aimed to characterize the mucosal cytokine tr...
Autores principales: | Goll, Rasmus, Moe, Øystein K., Johnsen, Kay-Martin, Meyer, Renate, Friestad, Joachim, Gundersen, Mona D., Kileng, Hege, Johnsen, Knut, Florholmen, Jon R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9670620/ https://www.ncbi.nlm.nih.gov/pubmed/36384462 http://dx.doi.org/10.1186/s12876-022-02559-5 |
Ejemplares similares
-
Prediction of long-term remission in patients following discontinuation of anti-TNF therapy in ulcerative colitis: a 10 year follow up study
por: Johnsen, Kay-Martin, et al.
Publicado: (2022) -
Discovery and validation of mucosal TNF expression combined with histological score - a biomarker for personalized treatment in ulcerative colitis
por: Florholmen, Jon R., et al.
Publicado: (2020) -
Hypo-osmotic stress induces the epithelial alarmin IL-33 in the colonic barrier of ulcerative colitis
por: Gundersen, Mona Dixon, et al.
Publicado: (2022) -
Head to head comparison of two commercial fecal calprotectin kits as predictor of Mayo endoscopic sub-score and mucosal TNF expression in ulcerative colitis
por: Goll, Rasmus, et al.
Publicado: (2019) -
Evaluation of anti-TNF therapeutic response in patients with inflammatory bowel disease: Current and novel biomarkers
por: Cui, Guanglin, et al.
Publicado: (2021)